According to a research report titled ‘Bone Growth Stimulators Market Size By Product, By End-use (Hospitals, Ambulatory Surgical Centers), By Application (Spinal Fusion Surgeries, Delayed Union & Non-union Bone Fractures, Oral And Maxillofacial Surgeries), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, bone growth stimulators market valuation is anticipated to reach USD 1.2 billion during 2019-2025.
 

Research findings state that increasing number of trauma incidents and growing prevalence of bone-related disorders are likely to boost bone growth stimulators market growth in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2144050/
 

Moreover, favorable government initiatives, and ongoing R&D activities aimed at technological advancement of bone growth stimulators are also anticipated to propel the industry valuation.
 

Despite the positive outlook, limited reimbursement scenario, and increasing incidents of product recall are likely to impede market growth during the forecast period.
 

Based on product type, global bone growth stimulators market is split into bone growth stimulation devices, platelet-rich plasma, and bone morphogenetic proteins. Under the bone growth stimulation devices, external bone growth stimulators segment accounted for over 40% market share in 2018 and is projected to record a similar growth rate during the forecast period, as these products offer a non-invasive solution and are effective as well as easy to use.
 

Furthermore, platelet-rich plasma will also gain considerable demand in the upcoming years, attributable to the zero risk of allergies associated with this product.
 

In the application segment, spinal fusion surgeries sector is estimated to register 6% CAGR during the forecast period. Increasing cases of spinal injuries, rising incidences of spinal stenosis and herniated disks and expanding geriatric population are fostering the segment growth.
 

Elaborating on the end-user scope, hospitals segment captured over 47% of the overall bone growth stimulators market share in 2018 and is projected to show remarkable growth in the ensuing years. The availability of skilled medical professionals, larger budgets, and expanding capacity to treat incoming patient volumes are propagating segmental development.
 

On the regional front, the U.S. market accounted for the largest share and is expected to grow at a CAGR of 5.9% over the study duration, owing to prompt adoption of advanced technology, availability of skilled professionals, as well as rising incidence of osteoporosis in the country. Additionally, factors such as growing geriatric population, high healthcare expenditure, and the presence of major market players are also promoting the industry growth in the nation.
 

Major contenders in bone growth stimulators market are Synergy Orthopedics LLC, Bioventus LLC, Zimmer Biomet Holdings Inc., Orthofix Medical Inc., Terumo Corp., Arthrex, Inc., DePuy Synthes, Stryker Corp., and Medtronic plc.